RT Journal Article
SR Electronic
T1 Adverse neonatal effects of maternal labetalol treatment
JF Archives of Disease in Childhood - Fetal and Neonatal Edition
JO Arch Dis Child Fetal Neonatal Ed
FD BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health
SP F150
OP F151
DO 10.1136/fn.79.2.F150
VO 79
IS 2
A1 B N A Crooks
A1 S A Deshpande
A1 C Hall
A1 M P Ward Platt
A1 D W A Milligan
YR 1998
UL http://fn.bmj.com/content/79/2/F150.abstract
AB Two infants with features of severe β adrenergic blockade, pericardial effusions, and myocardial hypertrophy were born to mothers receiving long term treatment with oral labetalol for hypertension in pregnancy. Labetalol was implicated in the aetiology of these problems. Pericardial effusion and myocardial hypertrophy have not been associated with labetalol toxicity in neonates.